NARA Discovery
Article Details
← Back to Search Results
Journal Article

The effect of adipose derived stromal cells on oxidative stress level, lung emphysema and white blood cells of guinea pigs model of chronic obstructive pulmonary disease

Ahmad Ghorbani; Azadeh Feizpour; Milad Hashemzahi; Lila Gholami; Mahmoud Hosseini; Mohammad Soukhtanloo; Farzaneh Vafaee Bagheri; Esmaeil Khodaei; Nema Mohammadian Roshan; Mohammad Hossein Boskabady
DARU Journal of Pharmaceutical Sciences · Vol. 22, Issue 1 · 2014

Abstract

Background Chronic obstructive pulmonary disease (COPD) is a worldwide epidemic disease and a major cause of death and disability. The present study aimed to elucidate pharmacological effects of adipose derived stromal cells (ASCs) on pathological and biochemical factors in a guinea pig model of COPD. Guinea pigs were randomized into 5 groups including: Control, COPD, COPD + intratracheal delivery of PBS as a vehicle (COPD-PBS), COPD + intratracheal delivery of ASCs (COPD-ITASC) and COPD + intravenous injection of ASCs (COPD-IVASC). COPD was induced by exposing animals to cigarette smoke for 3 months. Cell therapy was performed immediately after the end of animal exposure to cigarette smoke and 14 days after that, white blood cells, oxidative stress indices and pathological changes of the lung were measured. Results Compared with control group, emphysema was clearly observed in the COPD and COPD-PBS groups (p < 0.001). Lung histopathologic changes of COPD-ITASC and COPD-IVASC groups showed non-significant improvement compared to COPD-PBS group. The COPD-ITASC group showed a significant increase in total WBC compared to COPD-PBS group but there was not a significant increase in this regard in COPD-IVASC group. The differential WBC showed no significant change in number of different types of leukocytes. The serum level of malondialdehyde (MDA) significantly decreased but thiol groups of broncho-alveolar lavage fluid (BALF) increased in both cell treated groups (p < 0.05 for all cases). Weight of animals decreased during smoke exposure and improved after PBS or cell therapy. However, no significant change was observed between the groups receiving PBS and the ones receiving ASCs. Conclusion Cell therapy with ASCs can help in reducing oxidative damage during smoking which may collectively hold promise in attenuation of the severity of COPD although the lung structural changes couldn’t be ameliorated with these pharmacological therapeutic methods.

Bibliographic Information

JournalDARU Journal of Pharmaceutical Sciences
PublisherSpringer
Publication Date2014-12-01
Publication Year2014
Volume22
Issue1
Document TypeJournal Article
eISSN2008-2231
DOI10.1186/2008-2231-22-26

Access Information

NARA Access Coverage2012-01-01~Current
Journal Homepagehttps://www.springer.com/journal/40199
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.